The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Type 2 diabetes and the largest part of the evidence base — does this still hold?

This is a generated summary. It shows the 5 most-liked posts from a topic of 26, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
N
NorringtonTL3Regular23 Sep 2024#1
Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by np_gilmore on 18 Sep 2025.
  • 2 Dec 2024 — mira.patel: Replaced an unsourced figure with the published one and cited it.
  • 3 Jan 2025 — n.rowntree: Removed a claim that the cited source did not support.
  • 28 Nov 2024 — KTurkington: Clarified the distinction that was causing repeat questions below.
  • 18 Sep 2025 — np_gilmore: Added the worked example and a unit label to the table header.
Editors: mira.patel, n.rowntree, KTurkington, np_gilmore

Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below.

Trying to work out what would count as evidence on Type 2 diabetes, before collecting any. This is the part I usually skip and it is the part that makes the rest useful.

If two explanations predict the same observation, observing it does not help. So: what observation would separate them?

42 likes 22mo
L
LJankowiakTL3Regular26 Sep 2024#5

Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.

I have written this out at length because the short version keeps being misread.

30 likes 22mo
IT
integrator_traceTL2Member Solution29 Sep 2024#9
s.lundgren, post #6: Worth stating the null on Type 2 diabetes before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one. Go to post

Adding what did not work for me on Type 2 diabetes, since the failures never get written up and they are half the useful information.

7 likes in reply to #6 22mo
NB
n.bridgewaterTL2Member1 Oct 2024 · edited#13

Confirming post #10 from a second method, which matters more than confirming it from a second person.

If someone has run Type 2 diabetes properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.

32 likes 22mo
D
DKwiatkowskiTL3Regular6 Oct 2024#23

Nothing to add, except that this is the answer I would give if asked.

27 likes 22mo

Read the full topic (26 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Gastro-oesophageal reflux: improving or worsening?
The question in the title: Gastro-oesophageal reflux: improving or worsening? I will give what I have already checked below so nobody repeats it. Collecting what is known about gastro-oesophageal reflux in…
PMMNZDID+54 58 8.2k 1mo
About the Comorbidities category
Type 2 diabetes, hepatic steatosis, sleep apnoea, cardiovascular and renal disease. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
DOJMKHBMCE 4 16k 12h
Hypertension improvement and when medication needs revisiting
Hypertension improvement and when medication needs revisiting Writing it up because I had to work it out twice and would rather nobody else did. Hypertension improvement: setting out the arithmetic in full,…
ZCIMNBPSO+74 79 1.1k 10mo
Hepatic steatosis: what the MASH trial evidence supports — one year on
On the subject in the title: Hepatic steatosis: what the MASH trial evidence supports — one year on Working notes rather than a conclusion. Reading back through what has been written here about Hepatic…
VVSMG 2 4.1k 6mo
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class — setting out what I have, and where I think it stops being reliable. Something about Obstructive sleep apnoea does not reconcile and…
SVCLRF 2 726 14mo

Related topics — sharing the tags MASH / hepatic steatosis, chronic kidney disease, PCOS

TopicParticipantsRepliesViewsActivity
Chronic kidney disease and the FLOW result — a second dataset
Chronic kidney disease and the FLOW result — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Chronic kidney disease. It is mine,…
CTMMHH 2 2.3k 20mo
Why semaglutide solutions can look faintly opalescent and when that matters
The question in the title: Why semaglutide solutions can look faintly opalescent and when that matters I will give what I have already checked below so nobody repeats it. A follow-up question about…
DNGPRSDTMG+73 79 2k 4mo
The C-cell question: rodent findings and their human context
Posting this under the heading it deserves: The C-cell question: rodent findings and their human context Everything below is what sits behind that. The question about c-cell question that I actually want…
SGSRSTSLFR+41 45 24k 12mo
Insomnia at a dose step: reported experiences
On the subject in the title: Insomnia at a dose step: reported experiences Working notes rather than a conclusion. A sleep question with what I actually recorded rather than how I feel about it. Bedtime and…
MMIDFPVMSS+20 24 18k 8mo
Hypertension improvement and when medication needs revisiting — a second dataset
Posting this under the heading it deserves: Hypertension improvement and when medication needs revisiting — a second dataset Everything below is what sits behind that. Posting a small dataset on Hypertension…
RMKBMMSCDT+126 133 22k 21mo